SPECTRUM PHARMACEUTICALS INC 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Jun 15, 2017
Insider Transaction Report
Form 4
LENAZ LUIGI MD
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock, $0.001 par value
2017-06-13$6.48/sh−2,500$16,200→ 59,702 total - Award
Common Stock, $0.001 par value
2017-06-13+10,000→ 69,702 total - Award
Stock Option (Right to Buy)
2017-06-13+20,000→ 20,000 totalExercise: $6.48Exp: 2027-06-13→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
- [F2]100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders.
- [F3]25% of the option shares vested on June 13, 2017. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.